Letter: Rethinking the lower incidence of HCC in HIV-infected patients-A closer look at confounding factors. Authors' reply

Grace Lai-Hung Wong^{1

2}, Vicki Wing-Ki Hui^{1

2}, Yee-Tak Hui³, Grace Chung-Yan Lui¹

Affiliations

¹ Department of Medicine and Therapeutics, The Chinese University of Hong Kong, Hong Kong, Special Administrative Region, China.
² Medical Data Analytic Centre, The Chinese University of Hong Kong, Hong Kong, Special Administrative Region, China.
³ Queen Elizabeth Hospital, Hong Kong, Special Administrative Region, China.

Comment

Grace Lai-Hung Wong et al. Aliment Pharmacol Ther. 2023 Nov.

. 2023 Nov;58(9):958-959.

doi: 10.1111/apt.17713.

Grace Lai-Hung Wong^{1

2}, Vicki Wing-Ki Hui^{1

2}, Yee-Tak Hui³, Grace Chung-Yan Lui¹

¹ Department of Medicine and Therapeutics, The Chinese University of Hong Kong, Hong Kong, Special Administrative Region, China.
² Medical Data Analytic Centre, The Chinese University of Hong Kong, Hong Kong, Special Administrative Region, China.
³ Queen Elizabeth Hospital, Hong Kong, Special Administrative Region, China.

No abstract available

Comment on

Incidence of hepatocellular carcinoma and mortality in chronic viral hepatitis in an Asian population with and without HIV infection.
Lui GC, Hui VW, Sze SF, Wong BC, Cheung C, Lee MP, Yip TC, Tse YK, Lai JC, Chan HL, Wong VW, Hui YT, Wong GL. Lui GC, et al. Aliment Pharmacol Ther. 2023 Oct;58(8):814-823. doi: 10.1111/apt.17654. Epub 2023 Jul 28. Aliment Pharmacol Ther. 2023. PMID: 37515399

1. Lui GC, Hui VW, Sze SF, Wong BC, Cheung C, Lee MP, et al. Incidence of hepatocellular carcinoma and mortality in chronic viral hepatitis in an Asian population with and without HIV infection. Aliment Pharmacol Ther. 2023;58:814-823.
1. Shao GZ, Zhang W, Wu YF, Fan ZQ, Yang T, Lv GY. Letter: rethinking the lower incidence of HCC in HIV-infected patients - a closer look at confounding factors. Aliment Pharmacol Ther. 2023;58:956-957.
1. Wong GL, Hui VW, Yip TC, Liang LY, Zhang X, Tse YK, et al. Universal HBV vaccination dramatically reduces the prevalence of HBV infection and incidence of hepatocellular carcinoma. Aliment Pharmacol Ther. 2022;56:869-877.
1. Yip TC, Wong VW, Tse YK, Liang LY, Hui VW, Zhang X, et al. Similarly low risk of hepatocellular carcinoma after either spontaneous or nucleos(t)ide analogue-induced hepatitis B surface antigen loss. Aliment Pharmacol Ther. 2021;53:321-331.
1. Hui YT, Wong GLH, Fung JYY, Chan HLY, Leung NWY, Liu SD, et al. Territory-wide population-based study of chronic hepatitis C infection and implications for hepatitis elimination in Hong Kong. Liver Int. 2018;38:1911-1919.